Transdermal Drug Delivery Systems Market Anticipated to Attain USD 87.32 Billion Revenue by 2030, Claims AMR

The global transdermal drug delivery systems market generated $52.47 billion in 2020, and is expected to reach $87.32 billion by 2030, growing at a CAGR of 4.9% from 2021 to 2030.

Advantages over traditional delivery methods: Transdermal drug delivery systems offer several advantages over traditional drug delivery methods such as oral or injectable routes. These systems provide controlled drug release, improved bioavailability, reduced side effects, and enhanced patient compliance. They are particularly beneficial for drugs with a narrow therapeutic window.

Growing geriatric population: The aging population worldwide is driving the demand for transdermal drug delivery systems. Older adults often face difficulties in swallowing medications or may have impaired liver and kidney functions, making transdermal patches a preferred option for drug administration.

Expanding therapeutic applications: Initially, transdermal drug delivery systems were limited to a few therapeutic areas, such as hormone replacement therapy and pain management. However, the market has expanded to include a broader range of therapeutic applications, including cardiovascular diseases, neurological disorders, smoking cessation, and hormone therapy for menopause.

Technological advancements: Continuous research and development efforts have led to technological advancements in transdermal drug delivery systems. These advancements include the use of microneedles, iontophoresis, and various types of patches, enabling improved drug permeation through the skin and enhancing the efficiency of drug delivery.

Request Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/485

Market Drivers:

Convenience and patient compliance: Transdermal drug delivery systems offer convenience and improved patient compliance compared to other drug delivery methods. Patches eliminate the need for injections or frequent oral medication, providing a non-invasive and user-friendly approach. This convenience factor contributes to increased patient adherence to medication regimens.

Non-invasive drug delivery: Transdermal patches provide a non-invasive drug delivery method, which is particularly beneficial for patients who may have a fear of needles or experience difficulty swallowing medications. This feature makes transdermal drug delivery systems a preferred choice for pediatric, geriatric, and needle-phobic patients.

Market Segmentation:

By Type of Patch:

a. Matrix Patches: These patches consist of a drug-containing matrix that releases the drug through diffusion.

b. Reservoir Patches: These patches have a drug reservoir separated from the skin by a rate-controlling membrane. The drug is released through osmotic pressure or an external power source.

c. Drug-in-Adhesive Patches: These patches have the drug incorporated directly into the adhesive layer.

By Application:

a. Cardiovascular Diseases: Transdermal patches are used to deliver medications for conditions such as hypertension, angina, and arrhythmias.

b. Hormonal Disorders: Transdermal patches are used for hormone replacement therapy, contraception, and menopausal symptom management.

c. Pain Management: Transdermal patches deliver analgesics for chronic pain relief, such as opioids and non-steroidal anti-inflammatory drugs (NSAIDs).

d. Neurological Disorders: Patches are used for delivering medications for conditions like Parkinson's disease and Alzheimer's disease.

e. Smoking Cessation: Nicotine patches are commonly used to aid in smoking cessation.

By Distribution Channel:

a. Hospital Pharmacies: Transdermal patches are dispensed and administered within hospital settings.

b. Retail Pharmacies: Patches are available over-the-counter or prescribed by healthcare professionals in retail pharmacy settings.

c. Online Pharmacies: Patches can be purchased through online platforms and delivered to the patient's doorstep.

By Region:

a. North America: Including the United States and Canada.

b. Europe: Including countries like Germany, France, the United Kingdom, and Italy.

c. Asia Pacific: Including countries like China, India, Japan, South Korea, and Australia.

d. Latin America: Including countries like Brazil, Mexico, and Argentina.

e. Middle East and Africa: Including countries in the Middle East and Africa region.

It's important to note that these are general segments, and the market segmentation may vary based on specific reports or studies conducted in the industry.

Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/485

Competitive Landscape:

Johnson & Johnson Services, Inc.
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Hisamitsu Pharmaceutical Co., Inc.
GlaxoSmithKline plc
Purdue Pharma L.P.
Luye Pharma Group Ltd.
UCB S.A.
3M Company

Procure Complete Report at:

https://www.alliedmarketresearch.com/purchase-enquiry/485

Related Reports :

Pediatric Neurology Device Market: https://www.alliedmarketresearch.com/pediatric-neurology-device-market-A11670

Thyroid Ablation Devices Market: https://www.alliedmarketresearch.com/thyroid-ablation-devices-market-A13571

RNA Based Therapeutic Market: https://www.alliedmarketresearch.com/rna-based-therapeutics-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
Follow Us on | Facebook | LinkedIn | YouTube |

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.